Nitto Avecia Pharma Services, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 10 Vanderbilt, Irvine, California (CA) 92618, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 3012971227 · DUNS 116975565
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-07-25
- VAIDrug Quality Assurance2020-01-24
- VAIDrug Quality Assurance2017-04-21
- VAIDrug Quality Assurance2015-04-03
- VAIDrug Quality Assurance2015-02-20
- NAIDrug Quality Assurance2012-12-07
- NAIDrug Quality Assurance2012-04-02
- VAIDrug Quality Assurance2009-11-24
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- cemiplimab-rwlcRegeneron Pharmaceuticals, Inc.
- Verapamil HydrochlorideHospira, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.